MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/026921639400800206

Медицинская библиотека · Palliative medicine · 1994

The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study.

Johnson J R, Miller A J

Клиническое исследованиеСтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo. Assessments were made prior to and at one, two, three and four hours after dosing. Bone pain caused by metastatic cancer was significantly relieved one hour after the administration of 1500 mg CMT (p = 0.04). At all four time points the pain was less than baseline with CMT and at three time points greater than baseline with placebo but these results did not reach statistical significance. The summed pain intensity difference for patients was greater with CMT than with placebo, but this also did not reach significance. The incidence of volunteered side-effects was similar for both treatments. The results suggest that a nonacetylating, nonsteroidal anti-inflammatory drug may have a role complementary to that of an opioid in the management of metastatic bone pain.

Для цитирования: Johnson J R, Miller A J. The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study.. Palliative medicine. 1994. DOI: 10.1177/026921639400800206.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.